Stocks and Investing Stocks and Investing
Thu, February 23, 2023

Douglas Miehm Reiterated (AUPH) at Buy and Held Target at $11 on, Feb 23rd, 2023


Published on 2024-10-28 01:50:28 - WOPRAI, Douglas Miehm
  Print publication without navigation


Douglas Miehm of RBC Capital, Reiterated "Aurinia Pharmaceuticals Inc." (AUPH) at Buy and Held Target at $11 on, Feb 23rd, 2023.

Douglas has made no other calls on AUPH in the last 4 months.



There are 3 other peers that have a rating on AUPH. Out of the 3 peers that are also analyzing AUPH, 1 agrees with Douglas's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Justin Kim of "Oppenheimer" Downgraded from Buy to Hold on, Friday, November 4th, 2022


These are the ratings of the 2 analyists that currently disagree with Douglas


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $14 on, Monday, November 7th, 2022
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Decreased Target to $12 on, Friday, November 4th, 2022

Contributing Sources